Experience transformative weight loss with Novo-lela - Combo 4, featuring 30mg of Retatrutide and 4mg of Cagrilintide.
People may mix Retatrutide and Cagrilintide because both are injectable medications that target different pathways involved in appetite and weight regulation. Retatrutide, a GLP-1 receptor agonist, helps control blood sugar and reduce appetite, while Cagrilintide, an amylin analogue, promotes satiety and slows gastric emptying.
SlimGeniX is dedicated to offering effective GLP-1 therapy for sustainable weight loss and improved well-being. Transform your body and achieve your wellness goals with these powerful agents.
Novo-lela - Combo 4 - 30mg Retatrutide & 4mg Cagrilintide
Recommended Dosing Schedule Cagrilintide:
Dosage Instructions: Dose escalation Weekly dose Units to inject via insulin needle.
Week 1–4 Weekly dose of 0.25 mg 18 units
Week 5–8 Weekly dose of 0.5 mg 38 units
Week 9–12 Weekly dose of 1 mg 75 units.
Recommended Dosing Schedule Retatrutide:
Week 1–4 Weekly dose of 2mg 20 units once per weekWeek 5–8 Weekly dose of 4 mg 40 units once per week
Week 9–12 Weekly dose of 6 mg 60 units once per week
Week 13–16 Weekly dose of 8 mg 80 units (or 40 units 2x per week (EG: Mon, Thurs)
Week 17-20 Weekly dose of 10 mg 100 units (or 50 units 2x per week (EG: Mon, Thurs)
Week 21+Weekly dose of 12 mg 120 units (or 60 units 2x per week (EG: Mon, Thurs)
